0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antibody Drug"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$4,500USDGBP
From
EUR$4,500USDGBP
From
EUR$4,500USDGBP
From
EUR$4,500USDGBP
From
EUR$4,000USDGBP
From
EUR$4,500USDGBP
From
EUR$4,500USDGBP
From
EUR$4,500USDGBP
From
EUR$4,500USDGBP
From
EUR$4,750USDGBP
From
EUR$4,750USDGBP
From
EUR$4,750USDGBP
Biopharmaceuticals Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Biopharmaceuticals Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
EUR$4,150USDGBP
From
EUR$4,150USDGBP
RNA Interference Therapy-Competitive landscape, 2023 - Product Thumbnail Image

RNA Interference Therapy-Competitive landscape, 2023

  • Report
  • May 2023
  • 220 Pages
  • Global
From
EUR$3,500USDGBP
Loading Indicator

The Antibody Drug market is a subset of the biotechnology industry that focuses on the development and commercialization of therapeutic antibodies. Antibody drugs are used to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. These drugs are designed to target specific molecules in the body, such as proteins, hormones, and enzymes, and can be used to block or activate certain pathways. Antibody drugs are typically administered intravenously or subcutaneously, and can be used in combination with other drugs or therapies. The Antibody Drug market is highly competitive, with many companies investing in research and development to create new and improved treatments. Companies in the market are focused on developing novel antibodies, as well as improving existing treatments. Additionally, companies are investing in the development of biosimilars, which are generic versions of existing antibody drugs. Some companies in the Antibody Drug market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Novartis, Pfizer, Regeneron, Roche, and Sanofi. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more